II.1)
Scope of the procurement
Microarray Provision
Reference number:
BWPC ME905 RVJ
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
Supplies
II.1.4)
Short description
North Bristol NHS Trust is intending to purchase by way of seperate lots either a SNP Microarrays (capable of CNV detection and SNP genotyping) or equipment capable of large scale massively parallel (Next Generation) sequencing and scanning SNP Microarrays (capable of CNV detection and SNP genotyping) as part of the wider Pathology Sciences and the South West Genomic Laboratory Hub strategy and to meet the requirements of the NHSE National Genomic Test Directory for Cancer. Consideration will also be given for platforms that meet the requirements of the NHSE National Genomic Test Directory for Rare Disease and Cancer. The system must be capable of enabling batch flexibility to ensure efficient and responsive running of these urgent clinically urgent services.
II.1.5)
Estimated total value
Value excluding VAT: 800000.00
GBP
II.1.6)
Information about lots
This contract is divided into lots:
yes
Tenders may be submitted for
all lots
Microarray Provision
Lot No:
1
II.2.2)
Additional CPV code(s)
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.2.3)
Place of performance
Main site or place of performance:
South West Region
II.2.4)
Description of the procurement
The South West Genomics Laboratory Hub is intending to purchase equipment capable of scanning SNP Microarrays (capable of CNV detection and SNP genotyping) as part of the wider Pathology Sciences and the South West Genomic Laboratory Hub strategy and to meet the requirements of the NHSE National Genomic Test Directory for Cancer. The equipment is required to streamline current service delivery onto a consolidated pipeline suitable for Cancer investigations, including FFPE testing, as well as facilitating more specialised applications, for example combined methylation and copy number assessment or genome wide gene expression studies. Consideration will also be given for platforms that meet the requirements of the NHSE National Genomic Test Directory for Rare Disease and Cancer. The system must be capable of enabling batch flexibility to ensure efficient and responsive running of these urgent clinically urgent services.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 800000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
yes
Description of renewals:
Maintenance, support and consumables may be subject to annual renewals for up to five years after the initial 5 year contract duration. If contract fully extended, maximum term 10 years.
II.2.10)
Information about variants
Variants will be accepted:
yes
II.2.11)
Information about options
Options:
yes
Description of options:
Maintenance, support and consumables may be subject to annual renewals for up to five years after the initial 5 year contract duration. If contract fully extended, maximum term 10 years.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please ensure that you access and read all of the documentation contained in document folder
Microarray & Sequencer Provision
Lot No:
2
II.2.2)
Additional CPV code(s)
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.2.3)
Place of performance
Main site or place of performance:
South West Region
II.2.4)
Description of the procurement
The South West Genomics Laboratory Hub (SWGLH) is intending to purchase equipment capable of large scale massively parallel (Next Generation) sequencing and scanning SNP Microarrays (capable of CNV detection and SNP genotyping) as part of the wider Pathology Sciences and the South West Genomic Laboratory Hub strategy and to meet the requirements of the NHSE National Genomic Test Directory for Cancer and Rare Disease. The equipment is required to expand existing next generation sequencing capacity across the SWGLH Cancer and Rare Disease services and to streamline aspects of current and predicted service delivery onto a consolidated microarray pipeline suitable for Cancer and Rare Disease investigations.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 800000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
yes
Description of renewals:
Maintenance, support and consumables may be subject to annual renewals for up to five years after the initial 5 year contract duration. If contract fully extended, maximum term 10 years.
II.2.10)
Information about variants
Variants will be accepted:
yes
II.2.11)
Information about options
Options:
yes
Description of options:
Maintenance, support and consumables may be subject to annual renewals for up to five years after the initial 5 year contract duration. If contract fully extended, maximum term 10 years.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please ensure that you access and read all of the documentation contained in document folder